Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes

Neurology

Volumn 86, Issue 18, 2016, Pages 1736-1743

  Coyle Gilchrist, Ian T S ^a   Dick, Katrina M ^c   Patterson, Karalyn ^a   Rodríquez, Patricia Vázquez ^a   Wehmann, Eileen ^d   Wilcox, Alicia ^a   Lansdall, Claire J ^a   Dawson, Kate E ^a   Wiggins, Julie ^a   Mead, Simon ^c   Brayne, Carol ^b   Rowe, James B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONSENSUS; CORTICOBASAL DEGENERATION; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; INCIDENCE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PHENOTYPE; PICK PRESENILE DEMENTIA; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; PROSPECTIVE STUDY; SEMANTIC DEMENTIA; SEMI STRUCTURED INTERVIEW; SURVIVAL; UNITED KINGDOM; AGE; APHASIA; FRONTOTEMPORAL LOBAR DEGENERATION; PATHOPHYSIOLOGY; RISK; SUPRANUCLEAR PALSY, PROGRESSIVE; SURVIVAL ANALYSIS; SYNDROME;

ADULT; AGE FACTORS; AGED; APHASIA; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; RISK; SUPRANUCLEAR PALSY, PROGRESSIVE; SURVIVAL ANALYSIS; SYNDROME; UNITED KINGDOM;

EID: 84966460708     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002638     Document Type: Article

References (39)

1. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615-1621
2. Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry 2013; 25: 130-137
3. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphAsia and its Variants. Neurology 2011; 76: 1006-1014
4. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural Variant of frontotemporal dementia. Brain 2011; 134: 2456-2477
5. Armstrong MJ, LitVan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80: 496-503
6. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS Study. Brain 2009; 132: 156-171
7. Kipps CM, Hodges JR, Hornberger M. Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the bvFTD phenocopy syndrome. Curr Opin Neurol 2010; 23: 628-632
8. Ling H, Ling H, De Silva R, et al. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical Variant. Neuropathol Appl Neurobiol 2014; 40: 149-163
9. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain J Neurol 2005; 128(pt 9): 1996-2005
10. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009; 8: 270-279
11. Office for National Statistics. Annual mid-year population estimates for the UK, 2013. AVailable at: http://www.ons. gov.uk/ons/publications/re-reference-tables.html?edition5tcm%3A77-322718. Accessed June 5, 2015
12. Beck J, Pittman A, Adamson G, et al. Validation of nextgeneration sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging 2014; 35: 261-265
13. Cashman RE, Gerhardt PR, Goldberg ID, Handy VH, Levin ML. The probability of developing cancer. J Natl Cancer Inst 1956; 17: 155-173
14. EstèVe J, Benhamou E, Raymond L. Statistical methods in cancer research: Volume IV: descriptive epidemiology. IARC Sci Publ 1994; (128): 1-302
15. Alonso A, Logroscino G, Jick SS, Hernán MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol 2009; 16: 745-751
16. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 2003; 74: 1206-1209
17. Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain J Neurol 2003; 126(pt 9): 2016-2022
18. Ikejima C, Yasuno F, Mizukami K, Sasaki M, Tanimukai S, Asada T. Prevalence and causes of earlyonset dementia in Japan: a population-based study. Stroke 2009; 40: 2709-2714
19. Borroni B, Alberici A, Grassi M, et al. Is frontotemporal lobar degeneration a rare disorder? EVidence from a preliminary study in Brescia County, Italy. J Alzheimers Dis 2010; 19: 111-116
20. Gilberti N, Turla M, Alberici A, et al. Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica Study. Neurol Sci 2012; 33: 899-904
21. Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004; 62: 506-508
22. Golbe LI, Davis PH, Schoenberg BS, DuVoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38: 1031-1034
23. Schrag A, Ben-Shlomo Y, Quinn N. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999; 354: 1771-1775
24. Nath U, Ben-Shlomo Y, Thomson RG, et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001; 124: 1438-1449
25. Mercy L, Hodges JR, Dawson K, Barker RA, Brayne C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 2008; 71: 1496-1499
26. Garre-Olmo J, Genís Batlle D, del Mar Fernández M, et al. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology 2010; 75: 1249-1255
27. Ren RJ, Huang Y, Xu G, et al. History, present, and progress of frontotemporal dementia in China: a systematic review. Int J Alzheimers Dis 2012; 2012: e587215
28. Khan BK, Yokoyama JS, Takada LT, et al. Atypical, slowly progressive behavioural Variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry 2012; 83: 358-364
29. Kobylecki C, Jones M, Thompson JC, et al. Cognitivebehavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. J Neurol 2015; 262: 916-922
30. Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 2014; 29: 684-693
31. Winter Y, Bezdolnyy Y, Katunina E, et al. Incidence of Parkinson?s disease and atypical parkinsonism: Russian population-based study. Mov Disord 2010; 25: 349-356
32. Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB. Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 2014; 85: 925-929
33. Hodges JR, Davies RR, Xuereb JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406
34. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41-48
35. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick?s Disease. Arch Neurol 2001; 58: 1803-1809
36. Mendez MF, Joshi A, Tassniyom K, Teng E, Shapira JS.Clinicopathologic differences among patients with behavioral Variant frontotemporal dementia. Neurology 2013; 80: 561-568
37. LitVan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55: 97-105
38. Brayne C, McCracken C, Matthews FE. Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS). Int J Epidemiol 2006; 35: 1140-1145
39. Lashley T, Rohrer JD, Mead S, Revesz T. Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol 2015; 41: 858-881